See the published version of this preprint at BMC Ophthalmology.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
Case report
Xingtao Zhou
Eye and ENT Hospital of Fudan University
Corresponding Author
ORCiD: https://orcid.org/0000-0002-3465-1579
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: This report describes a case in which hyperopic femtosecond laser-assisted in situ keratomileusis (FS-LASIK) was performed following small incision lenticule extraction (SMILE) lenticule in situ implantation. Case presentation: The hyperopic left eye of a 46-year-old patient with refraction of +7.75 diopters sphere (DS)/-1.25 diopters cylinder (DC) 5° and corrected distance visual acuity (CDVA) of 20/50 mistakenly underwent the SMILE procedure for myopic astigmatism (-8.50 DS/-1.50 DC 175°) due to medical negligence. The extracted lenticule was subsequently re-implanted in situ. After 8 months, the left eye underwent FS-LASIK to correct hyperopia and astigmatism (+5.0 DS/-0.75 DC × 100°). Two years after FS-LASIK, corneal tomography showed no ectasia and microscopy revealed transparent cornea. The left eye exhibited CDVA of 20/50 with refraction of -0.75 DS/-0.25 DC × 165°. Conclusions: SMILE lenticule in situ implantation offers a solution for corneal volume and thickness restoration. FS-LASIK provides feasible correction of refractive error following lenticule re-implantation. Future studies are needed for determining the effectiveness of the treatment.
Keywords
SMILE, Lenticule, Re-implantation, refractive error
Figure 1
Figure 2
Figure 3
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at BMC Ophthalmology.
Version 3
Posted 13 Aug, 2019
No community comments so far
Submission checks complete
On 07 Nov, 2019
Editorial decision: Accept
On 31 Jul, 2019
No comments provided
Editorial decision: Minor revision
On 19 Jul, 2019
Reviewer #1 agreed
On 13 Jul, 2019
Review #1 received
Received 13 Jul, 2019
Reviewers invited
Invitations sent on 12 Jul, 2019
Editor assigned
On 04 Jul, 2019
Submission checks complete
On 03 Jul, 2019
Editor invited
On 03 Jul, 2019
No comments provided
Editorial decision: Major revision
On 10 Jun, 2019
Review #2 received
Received 06 Mar, 2019
Reviewer #2 agreed
On 24 Feb, 2019
Review #1 received
Received 23 Feb, 2019
Reviewer #1 agreed
On 18 Feb, 2019
Reviewers invited
Invitations sent on 18 Feb, 2019
Submission checks complete
On 08 Jan, 2019
Editor invited
On 08 Jan, 2019
Editor assigned
On 04 Jan, 2019
First submitted
On 24 Dec, 2018
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Internal Medicine Specialties
Learn more about our company.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
See the published version of this preprint at BMC Ophthalmology.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Case report
Xingtao Zhou
Eye and ENT Hospital of Fudan University
Corresponding Author
ORCiD: https://orcid.org/0000-0002-3465-1579
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at BMC Ophthalmology.
Version 3
Posted 13 Aug, 2019
No community comments so far
Submission checks complete
On 07 Nov, 2019
Editorial decision: Accept
On 31 Jul, 2019
No comments provided
Editorial decision: Minor revision
On 19 Jul, 2019
Reviewer #1 agreed
On 13 Jul, 2019
Review #1 received
Received 13 Jul, 2019
Reviewers invited
Invitations sent on 12 Jul, 2019
Editor assigned
On 04 Jul, 2019
Submission checks complete
On 03 Jul, 2019
Editor invited
On 03 Jul, 2019
No comments provided
Editorial decision: Major revision
On 10 Jun, 2019
Review #2 received
Received 06 Mar, 2019
Reviewer #2 agreed
On 24 Feb, 2019
Review #1 received
Received 23 Feb, 2019
Reviewer #1 agreed
On 18 Feb, 2019
Reviewers invited
Invitations sent on 18 Feb, 2019
Submission checks complete
On 08 Jan, 2019
Editor invited
On 08 Jan, 2019
Editor assigned
On 04 Jan, 2019
First submitted
On 24 Dec, 2018
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Internal Medicine Specialties
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at BMC Ophthalmology.
Background: This report describes a case in which hyperopic femtosecond laser-assisted in situ keratomileusis (FS-LASIK) was performed following small incision lenticule extraction (SMILE) lenticule in situ implantation. Case presentation: The hyperopic left eye of a 46-year-old patient with refraction of +7.75 diopters sphere (DS)/-1.25 diopters cylinder (DC) 5° and corrected distance visual acuity (CDVA) of 20/50 mistakenly underwent the SMILE procedure for myopic astigmatism (-8.50 DS/-1.50 DC 175°) due to medical negligence. The extracted lenticule was subsequently re-implanted in situ. After 8 months, the left eye underwent FS-LASIK to correct hyperopia and astigmatism (+5.0 DS/-0.75 DC × 100°). Two years after FS-LASIK, corneal tomography showed no ectasia and microscopy revealed transparent cornea. The left eye exhibited CDVA of 20/50 with refraction of -0.75 DS/-0.25 DC × 165°. Conclusions: SMILE lenticule in situ implantation offers a solution for corneal volume and thickness restoration. FS-LASIK provides feasible correction of refractive error following lenticule re-implantation. Future studies are needed for determining the effectiveness of the treatment.
Figure 1
Figure 2
Figure 3
This is a list of supplementary files associated with this preprint. Click to download.
Loading...